APX-008

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAPX-008
Drug Alias Nameanti-RANKL monoclonal antibodies - Apexigen/EpitomicsAPX-008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpitomics IncApexigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpitomics IncApexigen Inc
Active IndicationsN/A
Inactive IndicationsBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A